Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

ClinicalTrials.gov ID: NCT07173751

Public ClinicalTrials.gov record NCT07173751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 6:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multisite, Randomized, Double-Blind Trial of BNT327 in Combination With Chemotherapy Versus Placebo With Chemotherapy in Patients With Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC Determined Ineligible for PD(L)1 Therapy Based on PD-L1 Negative Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase III trial where participants will be randomized to two treatment groups, which means participants will be assigned by equal chance to a treatment group. This trial will be double-blinded, which means neither the participants nor the trial doctors will know which of the two treatments the participants actually receive. Participants will receive either the trial drug with chemotherapy or placebo (which looks like the trial drug but does not have any drug in it) with chemotherapy.

Study identification

NCT ID
NCT07173751
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
BioNTech SE
Industry
Enrollment
558 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 29, 2025
Primary completion
Nov 30, 2029
Completion
Aug 31, 2030
Last update posted
Aug 2, 2026

2025 – 2030

United States locations

U.S. sites
64
U.S. states
20
U.S. cities
52
Facility City State ZIP Site status
Highlands Oncology Group Springdale Arkansas 72762 Recruiting
University Of California - San Diego Moores Cancer Center La Jolla California 92037 Recruiting
Cedar Sinai - Samuel Oschin Cancer Center Los Angeles California 90048 Recruiting
Stanford University School of Medicine - Stanford Cancer Institute (SCI) - Stanford Women's Cancer Center Palo Alto California 94304-2201 Recruiting
University Of California Davis Health System Sacramento California 95817-2229 Recruiting
Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica California 90404-2312 Recruiting
Cancer Care Centers of Brevard, Inc Palm Bay Florida 32901 Recruiting
Sacred Heart Medical Oncology Group Pensacola Florida 32504 Recruiting
Cancer Care Specialists Decatur Illinois 62526 Recruiting
Cancer Care Specialists of Illinois O'Fallon Illinois 62269 Recruiting
Carle Foundation Hospital d/b/a Carle Cancer Center Urbana Illinois 61801 Recruiting
University Medical Center, Inc. DBA University of Louisville Hospital/James Graham Brown Cancer Center Louisville Kentucky 40202 Recruiting
New England Cancer Specialists Westbrook Maine 04092 Recruiting
Saint Agnes Hospital, Clinical Research Center Baltimore Maryland 21229 Recruiting
Maryland Oncology Hematology P.A. Columbia Maryland 21044 Recruiting
Lahey Hospital & Medical Center Burlington Massachusetts 01805 Recruiting
Karmanos Cancer Center Detroit Michigan 48201 Recruiting
Profound Research LLC at Michigan Hematology and Oncology Consultants Royal Oak Michigan 48073 Recruiting
Saint Luke's Hospital of Kansas City Kansas City Missouri 64111 Recruiting
Oncology Hematology West, PC dba Nebraska Cancer Specialist Grand Island Nebraska 68803 Recruiting
Paradigm Oncology Hematology West P.C. dba Nebraska Cancer Specialists Omaha Nebraska 68310 Recruiting
Summit Medical Group PA Florham Park New Jersey 07932 Recruiting
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) Livingston New Jersey 07039 Recruiting
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) Long Branch New Jersey 07740 Recruiting
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) New Brunswick New Jersey 08901 Recruiting
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) Newark New Jersey 07112 Recruiting
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) Somerville New Jersey 08876 Recruiting
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) Toms River New Jersey 08755 Recruiting
Paradigm New York Cancer and Blood Specialists Bay Shore New York 11706 Recruiting
Paradigm New York Cancer and Blood Specialists New York New York 10028 Recruiting
Paradigm New York Cancer and Blood Specialists New York New York 10469 Recruiting
Paradigm New York Cancer and Blood Specialists New York New York 11042 Recruiting
Paradigm New York Cancer and Blood Specialists New York New York 11210 Recruiting
Paradigm New York Cancer and Blood Specialists New York New York 11702 Recruiting
Paradigm New York Cancer and Blood Specialists New York New York 11772 Recruiting
Paradigm New York Cancer and Blood Specialists New York New York 11776 Recruiting
Paradigm New York Cancer and Blood Specialists New York New York 11901 Recruiting
Rochester General Hospital Lipson Cancer Institute Rochester New York 14621 Recruiting
Stony Brook University Medical Center Stony Brook New York 11794 Recruiting
Montefiore Medical Center The Bronx New York 10461 Recruiting
Oncology Specialists of Charlotte Pa Charlotte North Carolina 28204 Recruiting
Carolina Oncology Specialists Charlotte North Carolina 28210 Recruiting
St Charles Bend Cancer Center Bend Oregon 97701 Recruiting
St. Charles Cancer Center - Redmond Redmond Oregon 97756 Recruiting
Oregon Oncology Specialists Salem Oregon 97301 Recruiting
The West Clinic, P.C. dba West Cancer Center Germantown Tennessee 38002 Recruiting
Tennessee Oncology Nashville Tennessee 37203 Recruiting
OneR The Center For Cancer And Blood Disorders (Texas Cancer Care) Arlington Texas 76104 Recruiting
OneR The Center For Cancer And Blood Disorders (Texas Cancer Care) Burleson Texas 76028 Recruiting
UT Southwestern Medical Center at Redbird Dallas Texas 75237 Recruiting
University Of Texas Southwestern Medical Center Dallas Texas 75390 Recruiting
JPS Health Network - Trinity Springs Pavilion Fort Worth Texas 76104 Recruiting
OneR The Center For Cancer And Blood Disorders (Texas Cancer Care) Fort Worth Texas 76104 Recruiting
UT Southwestern Moncrief Cancer Institute Fort Worth Texas 76104 Recruiting
Oncology Consultants PA Houston Texas 77024 Recruiting
Oncology Consultants PA Houston Texas 77030 Recruiting
UT Southwestern Medical Center at Richardson/Plano Richardson Texas 75080 Recruiting
Renovatio Clinical - The Woodlands Research Center The Woodlands Texas 77380 Recruiting
OneR The Center For Cancer And Blood Disorders (Texas Cancer Care) Weatherford Texas 76068 Recruiting
Bon Secours Cancer Institute at Memorial Regional Mechanicsville Virginia 23116 Recruiting
Bon Secours St. Francis Medical Center Midlothian Virginia 23114 Recruiting
Bon Secours Cancer Institute at St. Mary's Richmond Virginia 23226 Recruiting
Northwest Medical Specialties, PLLC Tacoma Washington 98405 Recruiting
Medical College of Wisconsin Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 97 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07173751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 2, 2026 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07173751 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →